Ljubljana, Slovenia

Simon Skubin

This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent. Top assignee: Lek Pharmaceuticals D.d.. Active years: 2019.

USPTO Granted Patents = 1 


Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 23(Granted Patents)


Company Filing History:


Years Active: 2019

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Simon Skubin: Innovator in Pharmaceutical Composition

Introduction

Simon Skubin is a notable inventor based in Ljubljana, Slovenia. He has made significant contributions to the field of pharmaceuticals, particularly in the preparation of compositions that include poorly soluble active ingredients. His work is essential for developing effective treatments for various health conditions.

Latest Patents

Simon Skubin holds a patent for a process that prepares a pharmaceutical composition comprising a low soluble pharmaceutically active ingredient. This innovative composition is designed to generate a dosage form that effectively treats hypercholesterolemia. The patent highlights the importance of creating formulations that enhance the solubility and bioavailability of active ingredients.

Career Highlights

Simon Skubin is currently employed at Lek Pharmaceuticals D.d., a leading pharmaceutical company in Slovenia. His role involves research and development, focusing on improving drug formulations and delivery systems. His expertise in pharmaceutical sciences has positioned him as a valuable asset to his team.

Collaborations

Throughout his career, Simon has collaborated with talented professionals, including Rok Staric and Miha Homar. These collaborations have fostered a creative environment that encourages innovation and the development of new pharmaceutical solutions.

Conclusion

Simon Skubin's contributions to the pharmaceutical industry, particularly through his patent for a novel composition, demonstrate his commitment to advancing healthcare solutions. His work continues to impact the treatment of conditions like hypercholesterolemia, showcasing the importance of innovation in pharmaceuticals.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…